Annual SG&A
$5.55 M
-$486.00 K-8.05%
31 December 2023
Summary:
Titan Pharmaceuticals annual selling, general & administrative expenses is currently $5.55 million, with the most recent change of -$486.00 thousand (-8.05%) on 31 December 2023. During the last 3 years, it has fallen by -$253.00 thousand (-4.36%). TTNP annual SG&A is now -41.60% below its all-time high of $9.50 million, reached on 31 December 1995.TTNP Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$2.07 M
+$1.01 M+95.11%
30 June 2024
Summary:
Titan Pharmaceuticals quarterly selling, general & administrative expenses is currently $2.07 million, with the most recent change of +$1.01 million (+95.11%) on 30 June 2024. Over the past year, it has increased by +$433.00 thousand (+26.39%). TTNP quarterly SG&A is now -73.75% below its all-time high of $7.90 million, reached on 31 December 1996.TTNP Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$1.57 B
-$5.46 M-0.35%
30 June 2024
Summary:
Titan Pharmaceuticals TTM selling, general & administrative expenses is currently -$1.57 billion, with the most recent change of -$5.46 million (-0.35%) on 30 June 2024. Over the past year, it has dropped by -$1.57 billion (-29203.71%). TTNP TTM SG&A is now -4930.65% below its all-time high of $12.30 million, reached on 30 September 1997.TTNP TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTNP Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -8.1% | +26.4% | -10000.0% |
| 3 y3 years | -4.4% | +111.8% | -10000.0% |
| 5 y5 years | -19.2% | -31.4% | -10000.0% |
TTNP Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -8.1% | +11.2% | at high | +111.8% | -5.9% | at low |
| 5 y | 5 years | -19.2% | +11.2% | -31.4% | +152.7% | -15.7% | at low |
| alltime | all time | -41.6% | +98.1% | -73.8% | +152.7% | -4930.6% | at low |
Titan Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | $2.07 M(+95.1%) | $6.22 M(+15.7%) |
| Mar 2024 | - | $1.06 M(-26.4%) | $5.38 M(-3.1%) |
| Dec 2023 | $5.55 M(-8.1%) | $1.44 M(-12.0%) | $5.55 M(+2.9%) |
| Sept 2023 | - | $1.64 M(+33.5%) | $5.39 M(-3.0%) |
| June 2023 | - | $1.23 M(-0.4%) | $5.56 M(-6.5%) |
| Mar 2023 | - | $1.23 M(-4.3%) | $5.95 M(-1.5%) |
| Dec 2022 | $6.03 M(+20.9%) | $1.29 M(-28.6%) | $6.04 M(-5.6%) |
| Sept 2022 | - | $1.81 M(+11.6%) | $6.39 M(+14.9%) |
| June 2022 | - | $1.62 M(+22.4%) | $5.57 M(+11.7%) |
| Mar 2022 | - | $1.32 M(-19.8%) | $4.98 M(-0.1%) |
| Dec 2021 | $4.99 M(-14.0%) | $1.65 M(+68.3%) | $4.99 M(-2.0%) |
| Sept 2021 | - | $979.00 K(-5.4%) | $5.09 M(-6.4%) |
| June 2021 | - | $1.03 M(-22.0%) | $5.44 M(-3.3%) |
| Mar 2021 | - | $1.33 M(-24.1%) | $5.63 M(+0.7%) |
| Dec 2020 | $5.80 M(+7.4%) | $1.75 M(+31.8%) | $5.59 M(-5920.8%) |
| Sept 2020 | - | $1.33 M(+8.5%) | -$96.00 K(-106.0%) |
| June 2020 | - | $1.22 M(-5.1%) | $1.60 M(-55.7%) |
| Mar 2020 | - | $1.29 M(-132.8%) | $3.61 M(-33.2%) |
| Dec 2019 | $5.40 M(-21.3%) | -$3.94 M(-230.2%) | $5.40 M(-53.8%) |
| Sept 2019 | - | $3.02 M(-6.4%) | $11.69 M(+14.8%) |
| June 2019 | - | $3.23 M(+4.8%) | $10.19 M(+22.2%) |
| Mar 2019 | - | $3.08 M(+30.7%) | $8.33 M(+21.4%) |
| Dec 2018 | $6.87 M(+35.5%) | $2.36 M(+55.7%) | $6.87 M(+21.9%) |
| Sept 2018 | - | $1.51 M(+9.7%) | $5.63 M(+2.1%) |
| June 2018 | - | $1.38 M(-14.6%) | $5.52 M(+3.4%) |
| Mar 2018 | - | $1.61 M(+43.6%) | $5.33 M(+5.2%) |
| Dec 2017 | $5.07 M(+10.3%) | $1.13 M(-19.4%) | $5.07 M(-1.4%) |
| Sept 2017 | - | $1.40 M(+16.6%) | $5.14 M(+7.2%) |
| June 2017 | - | $1.20 M(-11.4%) | $4.80 M(-0.4%) |
| Mar 2017 | - | $1.35 M(+12.7%) | $4.82 M(+4.8%) |
| Dec 2016 | $4.60 M(+22.4%) | $1.20 M(+14.0%) | $4.60 M(+1.9%) |
| Sept 2016 | - | $1.05 M(-13.3%) | $4.51 M(+6.1%) |
| June 2016 | - | $1.21 M(+7.3%) | $4.25 M(+12.2%) |
| Mar 2016 | - | $1.13 M(+1.4%) | $3.79 M(+1.0%) |
| Dec 2015 | $3.75 M(+23.3%) | $1.11 M(+40.8%) | $3.75 M(+17.0%) |
| Sept 2015 | - | $792.00 K(+5.2%) | $3.21 M(-2.3%) |
| June 2015 | - | $753.00 K(-31.2%) | $3.29 M(+1.2%) |
| Mar 2015 | - | $1.09 M(+92.1%) | $3.25 M(+6.5%) |
| Dec 2014 | $3.05 M(-0.6%) | $570.00 K(-34.3%) | $3.05 M(-1.7%) |
| Sept 2014 | - | $867.00 K(+21.6%) | $3.10 M(+7.6%) |
| June 2014 | - | $713.00 K(-20.4%) | $2.88 M(+0.4%) |
| Mar 2014 | - | $896.00 K(+43.6%) | $2.87 M(-6.4%) |
| Dec 2013 | $3.06 M(-37.2%) | $624.00 K(-3.6%) | $3.06 M(-14.1%) |
| Sept 2013 | - | $647.00 K(-7.7%) | $3.57 M(-6.4%) |
| June 2013 | - | $701.00 K(-35.7%) | $3.81 M(-10.0%) |
| Mar 2013 | - | $1.09 M(-3.2%) | $4.23 M(-13.2%) |
| Dec 2012 | $4.88 M(+44.8%) | $1.13 M(+26.6%) | $4.88 M(+5.2%) |
| Sept 2012 | - | $890.00 K(-21.0%) | $4.64 M(+3.4%) |
| June 2012 | - | $1.13 M(-35.0%) | $4.49 M(+4.1%) |
| Mar 2012 | - | $1.73 M(+95.2%) | $4.31 M(+27.9%) |
| Dec 2011 | $3.37 M(+3.2%) | $888.00 K(+20.2%) | $3.37 M(+8.5%) |
| Sept 2011 | - | $739.00 K(-22.0%) | $3.10 M(+1.6%) |
| June 2011 | - | $948.00 K(+19.5%) | $3.06 M(-2.1%) |
| Mar 2011 | - | $793.00 K(+26.9%) | $3.12 M(-4.4%) |
| Dec 2010 | $3.26 M | $625.00 K(-9.6%) | $3.26 M(-2.7%) |
| Sept 2010 | - | $691.00 K(-31.7%) | $3.35 M(-5.2%) |
| June 2010 | - | $1.01 M(+8.2%) | $3.54 M(-9.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2010 | - | $935.00 K(+30.8%) | $3.92 M(+14.0%) |
| Dec 2009 | $3.44 M(-44.7%) | $715.00 K(-18.4%) | $3.44 M(+26.3%) |
| Sept 2009 | - | $876.00 K(-37.1%) | $2.72 M(-25.9%) |
| June 2009 | - | $1.39 M(+206.8%) | $3.67 M(-31.0%) |
| Mar 2009 | - | $454.00 K(-75.2%) | $5.33 M(-40.8%) |
| Sept 2008 | - | $1.83 M(-39.9%) | $9.00 M(+4.2%) |
| June 2008 | - | $3.04 M(+37.4%) | $8.64 M(+23.9%) |
| Mar 2008 | - | $2.21 M(+15.5%) | $6.97 M(+12.2%) |
| Dec 2007 | $6.21 M(+27.9%) | $1.92 M(+30.7%) | $6.21 M(+13.0%) |
| Sept 2007 | - | $1.47 M(+6.6%) | $5.50 M(+3.4%) |
| June 2007 | - | $1.38 M(-5.3%) | $5.32 M(+2.7%) |
| Mar 2007 | - | $1.45 M(+20.9%) | $5.18 M(+6.6%) |
| Dec 2006 | $4.86 M(-9.5%) | $1.20 M(-6.6%) | $4.86 M(-0.6%) |
| Sept 2006 | - | $1.29 M(+4.0%) | $4.89 M(-4.9%) |
| June 2006 | - | $1.24 M(+9.2%) | $5.14 M(-1.9%) |
| Mar 2006 | - | $1.13 M(-8.0%) | $5.24 M(-2.4%) |
| Dec 2005 | $5.37 M(+2.5%) | $1.23 M(-20.0%) | $5.37 M(-2.8%) |
| Sept 2005 | - | $1.54 M(+15.0%) | $5.52 M(+3.2%) |
| June 2005 | - | $1.34 M(+6.0%) | $5.35 M(+4.3%) |
| Mar 2005 | - | $1.26 M(-8.8%) | $5.13 M(-2.0%) |
| Dec 2004 | $5.24 M(+2.5%) | $1.38 M(+1.2%) | $5.24 M(+3.0%) |
| Sept 2004 | - | $1.37 M(+22.3%) | $5.08 M(+2.6%) |
| June 2004 | - | $1.12 M(-18.3%) | $4.96 M(-2.7%) |
| Mar 2004 | - | $1.37 M(+11.1%) | $5.09 M(-0.3%) |
| Dec 2003 | $5.11 M(+0.7%) | $1.23 M(-0.6%) | $5.11 M(+1.4%) |
| Sept 2003 | - | $1.24 M(-1.4%) | $5.04 M(-1.5%) |
| June 2003 | - | $1.26 M(-9.0%) | $5.11 M(-2.6%) |
| Mar 2003 | - | $1.38 M(+19.0%) | $5.25 M(+3.4%) |
| Dec 2002 | $5.08 M(-5.7%) | $1.16 M(-11.6%) | $5.08 M(-2.2%) |
| Sept 2002 | - | $1.31 M(-5.5%) | $5.19 M(+0.0%) |
| June 2002 | - | $1.39 M(+15.0%) | $5.19 M(+3.6%) |
| Mar 2002 | - | $1.21 M(-5.2%) | $5.01 M(-6.9%) |
| Dec 2001 | $5.38 M(+32.3%) | $1.28 M(-2.7%) | $5.38 M(+0.3%) |
| Sept 2001 | - | $1.31 M(+8.3%) | $5.37 M(+1.2%) |
| June 2001 | - | $1.21 M(-23.5%) | $5.30 M(+10.6%) |
| Mar 2001 | - | $1.58 M(+25.5%) | $4.80 M(+17.9%) |
| Dec 2000 | $4.07 M(+45.4%) | $1.26 M(+1.2%) | $4.07 M(+19.4%) |
| Sept 2000 | - | $1.25 M(+77.1%) | $3.41 M(+15.1%) |
| June 2000 | - | $704.00 K(-17.9%) | $2.96 M(+7.4%) |
| Mar 2000 | - | $857.00 K(+42.8%) | $2.76 M(+2.1%) |
| Dec 1999 | $2.80 M(-24.3%) | $600.00 K(-25.0%) | $2.70 M(-10.0%) |
| Sept 1999 | - | $800.00 K(+60.0%) | $3.00 M(0.0%) |
| June 1999 | - | $500.00 K(-37.5%) | $3.00 M(-14.3%) |
| Mar 1999 | - | $800.00 K(-11.1%) | $3.50 M(-5.4%) |
| Dec 1998 | $3.70 M(-43.1%) | $900.00 K(+12.5%) | $3.70 M(-22.9%) |
| Sept 1998 | - | $800.00 K(-20.0%) | $4.80 M(-12.7%) |
| June 1998 | - | $1.00 M(0.0%) | $5.50 M(-9.8%) |
| Mar 1998 | - | $1.00 M(-50.0%) | $6.10 M(-4.7%) |
| Dec 1997 | $6.50 M(+22.6%) | $2.00 M(+33.3%) | $6.40 M(-48.0%) |
| Sept 1997 | - | $1.50 M(-6.3%) | $12.30 M(+5.1%) |
| June 1997 | - | $1.60 M(+23.1%) | $11.70 M(+4.5%) |
| Mar 1997 | - | $1.30 M(-83.5%) | $11.20 M(+3.7%) |
| Dec 1996 | $5.30 M(-44.2%) | $7.90 M(+777.8%) | $10.80 M(+272.4%) |
| Sept 1996 | - | $900.00 K(-18.2%) | $2.90 M(+45.0%) |
| June 1996 | - | $1.10 M(+22.2%) | $2.00 M(+122.2%) |
| Mar 1996 | - | $900.00 K | $900.00 K |
| Dec 1995 | $9.50 M | - | - |
FAQ
- What is Titan Pharmaceuticals annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Titan Pharmaceuticals?
- What is Titan Pharmaceuticals annual SG&A year-on-year change?
- What is Titan Pharmaceuticals quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Titan Pharmaceuticals?
- What is Titan Pharmaceuticals quarterly SG&A year-on-year change?
- What is Titan Pharmaceuticals TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Titan Pharmaceuticals?
- What is Titan Pharmaceuticals TTM SG&A year-on-year change?
What is Titan Pharmaceuticals annual selling, general & administrative expenses?
The current annual SG&A of TTNP is $5.55 M
What is the all time high annual SG&A for Titan Pharmaceuticals?
Titan Pharmaceuticals all-time high annual selling, general & administrative expenses is $9.50 M
What is Titan Pharmaceuticals annual SG&A year-on-year change?
Over the past year, TTNP annual selling, general & administrative expenses has changed by -$486.00 K (-8.05%)
What is Titan Pharmaceuticals quarterly selling, general & administrative expenses?
The current quarterly SG&A of TTNP is $2.07 M
What is the all time high quarterly SG&A for Titan Pharmaceuticals?
Titan Pharmaceuticals all-time high quarterly selling, general & administrative expenses is $7.90 M
What is Titan Pharmaceuticals quarterly SG&A year-on-year change?
Over the past year, TTNP quarterly selling, general & administrative expenses has changed by +$433.00 K (+26.39%)
What is Titan Pharmaceuticals TTM selling, general & administrative expenses?
The current TTM SG&A of TTNP is -$1.57 B
What is the all time high TTM SG&A for Titan Pharmaceuticals?
Titan Pharmaceuticals all-time high TTM selling, general & administrative expenses is $12.30 M
What is Titan Pharmaceuticals TTM SG&A year-on-year change?
Over the past year, TTNP TTM selling, general & administrative expenses has changed by -$1.57 B (-29203.71%)